Brown, D. A. et al. Mitochondrial perform as a therapeutic goal in coronary heart failure. Nat. Rev. Cardiol. 14, 238–250 (2017).
Godoy, L. C. et al. Affiliation of beta-blocker remedy with cardiovascular outcomes in sufferers with steady ischemic coronary heart illness. J. Am. Coll. Cardiol. 81, 2299–2311 (2023).
Cohn, P. F., Fox, Ok. M. & Daly, C. Silent myocardial ischemia. Circulation 108, 1263–1277 (2003).
Ibanez, B. et al. 2017 ESC Tips for the administration of acute myocardial infarction in sufferers presenting with ST-segment elevation: the Process Power for the administration of acute myocardial infarction in sufferers presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Coronary heart J. 39, 119–177 (2018).
Ikeda, G. et al. Mitochondria-rich extracellular vesicles from autologous stem cell-derived cardiomyocytes restore energetics of ischemic myocardium. J. Am. Coll. Cardiol. 77, 1073–1088 (2021).
Solar, M. et al. Mitochondrial transplantation as a novel therapeutic technique for cardiovascular illnesses. J. Transl. Med. 21, 347 (2023).
Bertero, E., Maack, C. & O’Rourke, B. Mitochondrial transplantation in people: ‘magical’ remedy or trigger for concern? J. Clin. Make investments. 128, 5191–5194 (2018).
Lightowlers, R. N., Chrzanowska-Lightowlers, Z. M. & Russell, O. M. Mitochondrial transplantation—a attainable therapeutic for mitochondrial dysfunction? Mitochondrial switch is a possible remedy for a lot of illnesses however proof of efficacy and security remains to be missing. EMBO Rep. 21, e50964 (2020).
Zhang, T. & Miao, C. Mitochondrial transplantation as a promising remedy for mitochondrial illnesses. Acta Pharm. Sin. B 13, 1028–1035 (2023).
McCully, J. D. et al. Injection of remoted mitochondria throughout early reperfusion for cardioprotection. Am. J. Physiol. Coronary heart Circ. Physiol. 296, H94–H105 (2009).
Solar, X. et al. Alda-1 remedy promotes the therapeutic impact of mitochondrial transplantation for myocardial ischemia-reperfusion harm. Bioact. Mater. 6, 2058–2069 (2021).
Hayashida, Ok. et al. Exogenous mitochondrial transplantation improves survival and neurological outcomes after resuscitation from cardiac arrest. BMC Med. 21, 56 (2023).
Baryakova, T. H., Pogostin, B. H., Langer, R. & McHugh, Ok. J. Overcoming limitations to affected person adherence: the case for creating revolutionary drug supply methods. Nat. Rev. Drug Discov. 22, 387–409 (2023).
Chen, W., Huang, T., Shi, Ok., Chu, B. & Qian, Z. Chemotaxis-based self-accumulation of surface-engineered mitochondria for most cancers therapeutic enchancment. Nano In the present day 35, 100966 (2020).
Chen, H. et al. A nitric-oxide pushed chemotactic nanomotor for enhanced immunotherapy of glioblastoma. Nat. Commun. 14, 941 (2023).
Tang, S. et al. Enzyme-powered Janus platelet cell robots for lively and focused drug supply. Sci. Robotic. 5, eaba6137 (2020).
Lanza, I. R. & Nair, Ok. S. Practical evaluation of remoted mitochondria in vitro. Strategies Enzymol. 457, 349–372 (2009).
Heitzer, T., Schlinzig, T., Krohn, Ok., Meinertz, T. & Münzel, T. Endothelial dysfunction, oxidative stress, and threat of cardiovascular occasions in sufferers with coronary artery illness. Circulation 104, 2673–2678 (2001).
Li, T. et al. A common chemotactic focused supply technique for inflammatory illnesses. Adv. Mater. 34, e2206654 (2022).
Somasundar, A. et al. Constructive and detrimental chemotaxis of enzyme-coated liposome motors. Nat. Nanotechnol. 14, 1129–1134 (2019).
Michela, P., Velia, V., Aldo, P. & Ada, P. Position of connexin 43 in cardiovascular illnesses. Eur. J. Pharmacol. 768, 71–76 (2015).
Bennett, B. C. et al. An electrostatic mechanism for Ca2+-mediated regulation of hole junction channels. Nat. Commun. 7, 8770 (2016).
Islam, M. N. et al. Mitochondrial switch from bone-marrow-derived stromal cells to pulmonary alveoli protects in opposition to acute lung harm. Nat. Med. 18, 759–765 (2012).
Gadok, A. Ok. et al. Connectosomes for direct molecular supply to the mobile cytoplasm. J. Am. Chem. Soc. 138, 12833–12840 (2016).
Chen, P. et al. A plant-derived pure photosynthetic system for enhancing cell anabolism. Nature 612, 546–554 (2022).
Huang, T. et al. Iron oxide nanoparticles increase the intercellular mitochondrial transfer-mediated remedy. Sci. Adv. 7, eabj0534 (2021).
Massion, P. B., Feron, O., Dessy, C. & Balligand, J.-L. Nitric oxide and cardiac perform: ten years after, and persevering with. Circ. Res. 93, 388–398 (2003).
Manders, E. M. M., Verbeek, F. J. & Aten, J. A. Measurement of co-localization of objects in dual-colour confocal photographs. J. Microsc. 169, 375–382 (1993).
Zhu, P. et al. Ripk3 promotes ER stress-induced necroptosis in cardiac IR harm: a mechanism involving calcium overload/XO/ROS/mPTP pathway. Redox Biol. 16, 157–168 (2018).
Han, X. et al. Zwitterionic micelles effectively ship oral insulin with out opening tight junctions. Nat. Nanotechnol. 15, 605–614 (2020).
Zhou, Y. et al. A pH‐triggered self‐unpacking capsule containing zwitterionic hydrogel‐coated MOF nanoparticles for environment friendly oral exendin‐4 supply. Adv. Mater. 33, e2102044 (2021).
Zhu, W. et al. Oral supply of therapeutic antibodies with a transmucosal polymeric provider. ACS Nano 17, 4373–4386 (2023).
Pearce, S. C. et al. Intestinal in vitro and ex vivo fashions to review host–microbiome interactions and acute stressors. Entrance. Physiol. 9, 1584 (2018).
Drucker, D. J. Advances in oral peptide therapeutics. Nat. Rev. Drug Discov. 19, 277–289 (2020).
Yellon, D. M. & Hausenloy, D. J. Myocardial reperfusion harm. N. Engl. J. Med. 357, 1121–1135 (2007).
Zhang, A. et al. Supply of mitochondria confers cardioprotection by means of mitochondria replenishment and metabolic compliance. Mol. Ther. 31, 1468–1479 (2023).
Tevaearai, H. T., Walton, G. B., Eckhart, A. D., Keys, J. R. & Koch, W. J. Donor coronary heart contractile dysfunction following extended ex vivo preservation will be prevented by gene-mediated β-adrenergic signaling modulation. Eur. J. Cardiothorac. Surg. 22, 733–737 (2002).
Tang, X. et al. Lipophilic NO‐pushed nanomotors as drug balloon coating for the remedy of atherosclerosis. Small 19, 2203238 (2023).
Zhang, Q. et al. Neutrophil membrane-coated nanoparticles inhibit synovial irritation and alleviate joint harm in inflammatory arthritis. Nat. Nanotechnol. 13, 1182–1190 (2018).
Chen, W., Shi, Ok., Chu, B., Wei, X. & Qian, Z. Mitochondrial floor engineering for multidrug resistance reversal. Nano Lett. 19, 2905–2913 (2019).
Xie, C. et al. Irisin controls progress, intracellular Ca2+ alerts, and mitochondrial thermogenesis in cardiomyoblasts. PLoS One 10, e0136816 (2015).
Dagda, R. Ok. et al. Lack of PINK1 perform promotes mitophagy by means of results on oxidative stress and mitochondrial fission. J. Biol. Chem. 284, 13843–13855 (2009).
Vandergriff, A. C., Hensley, M. T. & Cheng, Ok. Isolation and cryopreservation of neonatal rat cardiomyocytes. J. Vis. Exp. 9, e52726 (2015).
Yamagata, T. et al. Characterization of insulin safety properties of complexation hydrogels in gastric and intestinal enzyme fluids. J. Management. Launch 112, 343–349 (2006).
Rabiolo, A., Bignami, F., Rama, P. & Ferrari, G. VesselJ: a brand new instrument for semiautomatic measurement of corneal neovascularization. Make investments. Ophthalmol. Vis. Sci. 56, 8199–8206 (2015).
Masuzawa, A. et al. Transplantation of autologously derived mitochondria protects the center from ischemia-reperfusion harm. Am. J. Physiol. Coronary heart Circ. Physiol. 304, H966–H982 (2013).
Cowan, D. B. et al. Intracoronary supply of mitochondria to the ischemic coronary heart for cardioprotection. PLoS One 11, e0160889 (2016).
Kaza, A. Ok. et al. Myocardial rescue with autologous mitochondrial transplantation in a porcine mannequin of ischemia/reperfusion. J. Thorac. Cardiovasc. Surg. 153, 934–943 (2017).
Shin, B. et al. A novel organic technique for myocardial safety by intracoronary supply of mitochondria: security and efficacy. JACC Fundamental Transl. Sci. 4, 871–888 (2019).
Blitzer, D. et al. Delayed transplantation of autologous mitochondria for cardioprotection in a porcine mannequin. Ann. Thorac. Surg. 109, 711–719 (2020).
Guariento, A. et al. Mitochondrial transplantation for myocardial safety in ex-situ-perfused hearts donated after circulatory dying. J. Coronary heart Lung Transplant. 39, 1279–1288 (2020).
Guariento, A. et al. Preischemic autologous mitochondrial transplantation by intracoronary injection for myocardial safety. J. Thorac. Cardiovasc. Surg. 160, e15–e29 (2020).
Solar, X. et al. Intravenous transplantation of an ischemic-specific peptide-TPP-mitochondrial compound alleviates myocardial ischemic reperfusion harm. ACS Nano 17, 896–909 (2023).
Emani, S. M., Piekarski, B. L., Harrild, D., Del Nido, P. J. & McCully, J. D. Autologous mitochondrial transplantation for dysfunction after ischemia-reperfusion harm. J. Thorac. Cardiovasc. Surg. 154, 286–289 (2017).
Guariento, A. et al. Autologous mitochondrial transplantation for cardiogenic shock in pediatric sufferers following ischemia-reperfusion harm. J. Thorac. Cardiovasc. Surg. 162, 992–1001 (2021).
Kristensen, Ok. L., Rauer, L. J., Mortensen, P. E. & Kjeldsen, B. J. Reoperation for bleeding in cardiac surgical procedure. Work together. Cardiovasc. Thorac. Surg. 14, 709–713 (2012).
Zubrzycki, M. et al. Evaluation and pathophysiology of ache in cardiac surgical procedure. J. Ache. Res. 11, 1599–1611 (2018).
Tanner, T. G. & Colvin, M. O. Pulmonary issues of cardiac surgical procedure. Lung 198, 889–896 (2020).
Kubota, H. et al. Deep sternal wound an infection after cardiac surgical procedure. J. Cardiothorac. Surg. 8, 132 (2013).
Doll, J. A. et al. Administration of percutaneous coronary intervention issues: algorithms from the 2018 and 2019 Seattle percutaneous coronary intervention issues convention. Circ. Cardiovasc. Interv. 13, e008962 (2020).
Stern, S. & Bayes de Luna, A. Coronary artery spasm: a 2009 replace. Circulation 119, 2531–2534 (2009).